Published in Mod Pathol on April 01, 1997
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia (2012) 1.93
Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma. J Korean Med Sci (2005) 1.19
TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma. Int J Clin Exp Pathol (2012) 0.85
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer (1981) 5.89
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res (1969) 2.63
Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis (1996) 2.12
Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma (2000) 1.94
Children of depressed parents. Increased psychopathology and early onset of major depression. Arch Gen Psychiatry (1987) 1.88
Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity. N Engl J Med (1973) 1.85
Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol (1997) 1.69
Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med (1994) 1.68
Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol (1991) 1.67
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol (1990) 1.53
Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood (1993) 1.50
Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant (2002) 1.49
The assessment of social adjustment. An update. Arch Gen Psychiatry (1981) 1.42
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J Infect Dis (1998) 1.40
Parent and child reports of depressive symptoms in children at low and high risk of depression. J Child Psychol Psychiatry (1987) 1.40
The Social Adjustment Inventory for Children and Adolescents (SAICA): testing of a new semistructured interview. J Am Acad Child Adolesc Psychiatry (1987) 1.38
Gelatinous transformation of bone marrow in prolonged self-induced starvation. Scand J Haematol (1976) 1.38
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Ann Hematol (1992) 1.24
Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood (1993) 1.18
Incidence and importance of splenic sarcoid-like granulomas. Arch Pathol Lab Med (1977) 1.13
Assessing psychiatric disorders in children. Discrepancies between mothers' and children's reports. Arch Gen Psychiatry (1987) 1.13
Family-genetic studies of psychiatric disorders. Developing technologies. Arch Gen Psychiatry (1986) 1.13
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases. Cancer (1979) 1.11
The epidemiology of Tourette's syndrome: a pilot study. Schizophr Bull (1982) 1.10
Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med (1987) 1.08
A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood (1994) 1.07
Peliosis of the spleen. Am J Clin Pathol (1979) 1.06
The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma. Cancer (1989) 1.06
Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature. Cancer (1978) 1.03
Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits. Am J Kidney Dis (2001) 1.02
Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia (1991) 1.02
Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol (1997) 1.01
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol (1996) 0.99
Uraemia and mast-cell proliferation. Lancet (1972) 0.99
Leukemic meningitis complicating early stage chronic lymphocytic leukemia. Arch Pathol Lab Med (1997) 0.99
Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study. Neurosurgery (2001) 0.98
CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Am J Clin Pathol (1994) 0.97
Experimental myocardial infarction. I. Production of left ventricular failure by gradual coronary occlusion in intact conscious dogs. Cardiovasc Res (1970) 0.97
T8 chronic lymphocytic leukemia. A distinctive disorder related to T8 lymphocytosis. Am J Clin Pathol (1983) 0.96
Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials. The Eastern Cooperative Oncology Group experience. Cancer (1988) 0.95
Depressed parents and their children. General health, social, and psychiatric problems. Am J Dis Child (1986) 0.94
CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Am J Hematol (1994) 0.93
In vitro effect of vegetable and fruit juices on the mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Food Chem Toxicol (1994) 0.92
The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis. Am J Clin Pathol (1991) 0.91
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. J Clin Oncol (1992) 0.91
Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol (1997) 0.91
"Lennert's lymphoma" with transformation to malignant lymphoma, histiocytic type (immunoblastic sarcoma). Am J Clin Pathol (1977) 0.90
Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissue. Hum Pathol (1992) 0.90
Non-Hodgkin's lymphoma and occupational exposure. Cancer Res (1992) 0.90
Peripheral T-cell lymphoma: a clinicopathologic study of nine cases. Am J Clin Pathol (1983) 0.90
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol (1997) 0.89
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation. Gene Ther (2009) 0.89
Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc Natl Acad Sci U S A (1996) 0.89
The histologic features of hyperplastic lymphadenopathy in AIDS-related complex are nonspecific. Am J Surg Pathol (1987) 0.88
Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst (1982) 0.88
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin Diagn Lab Immunol (1994) 0.88
Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol (1987) 0.87
Medical literature searches--how many bibliographic databases are needed for sufficient retrieval in medical topics? Methods Inf Med (1985) 0.87
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Mol Dis (1998) 0.87
Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. J Neurooncol (2011) 0.87
Malignant lymphoma presenting in the orbit: a clinicopathologic study of a rare immunoglobulin-producing variant. Cancer (1981) 0.86
Immunoblastic sarcoma. Am J Surg Pathol (1982) 0.86
In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors. Cancer Res (1990) 0.86
Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Mod Pathol (1993) 0.85
Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol (1998) 0.85
Primary hepatic B-cell lymphoma in a child. Am J Surg Pathol (1993) 0.84
Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients. Cancer Genet Cytogenet (1996) 0.84
Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An Eastern Cooperative Oncology Group (ECOG) study. Cancer (1990) 0.84
The pathology of the spleen in steroid-treated immune thrombocytopenic purpura. Am J Clin Pathol (1985) 0.84
Nuclear bud formation: a novel manifestation of Zidovudine genotoxicity. Cytogenet Genome Res (2010) 0.84
Forced normalization. Acute psychosis after seizure control in seven patients. Arch Neurol (1987) 0.84
Seasonal variations in the levels of PAH-DNA adducts in young adults living in Mexico City. Mutagenesis (2010) 0.84
Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA. Mod Pathol (1994) 0.84
Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol (1994) 0.83
Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2. Cancer (1989) 0.83
In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood (1993) 0.83
Hypersplenism in the uremic hemodialyzed patient: pathology and proposed pathophysiologic mechanisms. Am J Clin Pathol (1973) 0.83
Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study. Blood (1996) 0.83
Multiple myeloma associated with myelofibrosis. Report of a case and literature review. Oncology (1981) 0.83
Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy. J Clin Oncol (1984) 0.83
Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). Am J Clin Pathol (2000) 0.82
Depression and social adjustment among chronic schizophrenic outpatients. J Nerv Ment Dis (1981) 0.82
The assessment of lifetime psychopathology: a comparison of two interviewing styles. Psychol Med (1988) 0.82
Use of a structured diagnostic interview to identify bipolar disorder in adolescent inpatients: frequency and manifestations of the disorder. Am J Psychiatry (1983) 0.82
Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. Am J Clin Pathol (1994) 0.82
Peliosis hepatis in hematologic disease. Report of two cases. JAMA (1978) 0.82
Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. J Pediatr Surg (1998) 0.82